Mast Cell Activation Syndrome Clinical Trials

9 clinical trials for Mast Cell Activation Syndrome across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Assessment of somatosensory profiles using quantitative sensory testing (QST) in patients with mast cell activation disease (MCAD) — RECRUITING
• Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — RECRUITING
• A PHASE 2 MULTICENTER STUDY OF TL-895 IN SUBJECTS WITH MYELOFIBROSIS, INDOLENT SYSTEMIC MASTOCYTOSIS, MONOCLONAL MAST CELL ACTIVATION SYNDROME, OR NONMONOCLONAL MAST CELL ACTIVATION SYNDROME — RECRUITING · PHASE2
• Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) — TERMINATED · PHASE2
• Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome? — SUSPENDED · NA
• A 24-week, multicenter, randomized, double blind, placebo-controlled, dose-range finding phase II study to compare efficacy and safety of oral masitinib to placebo in treatment of patients with severe mast cell activation syndrome (MCAS) with handicap unresponsive to optimal symptomatic treatment — OTHER · PHASE2
• Masitinib for the Treatment of Severe Mast Cell Activation Syndrome — OTHER · PHASE2
• Ocular and Palpebral Manifestations of Mastocytosis (MOOMA) — COMPLETED · NA
• Mast Cell Activation Test in Allergic Disease — COMPLETED

Refine this search